Literature DB >> 6497459

Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor.

I Teitsson, R H Withrington, M H Seifert, H Valdimarsson.   

Abstract

Thirty-three patients with early arthritis, 28 of whom developed classical/definite rheumatoid arthritis (RA), were followed up for two to four years. Rheumatoid factor (RF) levels of the IgM, IgA, and IgG isotypes were measured in serum and synovial fluid by an ELISA technique developed in our laboratory. All seven patients who presented with raised IgA RF developed erosions of their hands and wrists. This was significantly different from the remaining 26. By contrast none of the five patients who presented with isolated elevation of IgM RF developed erosive disease. The patients with raised IgA RF needed significantly more treatment with 'specific' drugs than the remaining 26. It is suggested that the detection of IgA RF in early RA indicates poor prognosis, justifying a more aggressive treatment at an early stage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6497459      PMCID: PMC1001507          DOI: 10.1136/ard.43.5.673

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

1.  Enzyme immunoassays in diagnostic medicine. Theory and practice.

Authors:  A Voller; D E Bidwell; A Bartlett
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

2.  COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.

Authors:  J J DUTHIE; P E BROWN; L H TRUELOVE; F D BARAGAR; A J LAWRIE
Journal:  Ann Rheum Dis       Date:  1964-05       Impact factor: 19.103

3.  REACTION OF 7S AND 19S COMPONENTS OF IMMUNE RABBIT ANTISERA WITH HUMAN GROUP A AND AB RED CELLS.

Authors:  C L GREENBURY; D H MOORE; L A NUNN
Journal:  Immunology       Date:  1963-09       Impact factor: 7.397

4.  Significance of the Waaler-Rose test, streptococcal agagglutination, and antistreptolysin titre in the prognosis of rheumatoid arthritis.

Authors:  H A OTTEN; F W BOERMA
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

5.  Relationship of radiological change to clinical outcome in rheumatoid arthritis.

Authors:  A Brook; A Fleming; M Corbett
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

6.  Evaluation of the RAHA test for rheumatoid factor.

Authors:  A Finnie; M Mason; C Muir
Journal:  Med Lab Technol       Date:  1974-10

7.  Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities.

Authors:  J T Sharp; M D Lidsky; L C Collins; J Moreland
Journal:  Arthritis Rheum       Date:  1971 Nov-Dec

Review 8.  A "trans" perspective on the control of immunoglobulin c gene expression.

Authors:  A Coutinho; R Benner; M Björklund; L Forni; D Holmberg; F Ivars; C Martinez-A; S Pettersson
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

9.  International reference preparation of rheumatoid arthritis serum.

Authors:  S G Anderson; M W Bentzon; V Houba; P Krag
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

10.  Incidence and specificities of IgA and IgM anti-AgG autoantibodies in various mouse strains and colonies.

Authors:  J L van Snick; P L Masson
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

View more
  40 in total

1.  Significance of rheumatoid factors in an eight-year longitudinal study on arthritis.

Authors:  T Tuomi; K Aho; T Palosuo; K Kaarela; R von Essen; H Isomäki; M Leirisalo-Repo; S Sarna
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

Review 2.  B-cell involvement in the pathogenesis of RA-is there a contribution of the sympathetic nervous system?

Authors:  Georg Pongratz; Rainer H Straub
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Value of joint scintigraphy in the prediction of erosiveness in early rheumatoid arthritis.

Authors:  T T Möttönen; P Hannonen; J Toivanen; A Rekonen; M Oka
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

4.  Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis.

Authors:  L Vasiliauskiene; A Wiik; M Høier-Madsen
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

5.  Significance of rheumatoid factor isotypes in seronegative rheumatoid arthritis.

Authors:  F Eggelmeijer; H G Otten; H H de Rooy; M R Daha; F C Breedveld
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

6.  Enzyme-linked immunosorbent assay (ELISA) screening test for detection of rheumatoid factor.

Authors:  T Jonsson; J A Arnason; H Valdimarsson
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

Review 7.  New perspectives of secondary and tertiary therapy for rheumatoid arthritis.

Authors:  R F Willkens
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

8.  Serum immune complexes containing IgA appear to predict erosive arthritis in a longitudinal study in rheumatoid arthritis.

Authors:  M L Westedt; M R Daha; W M Baldwin; T Stijnen; A Cats
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

9.  IgA-anti-yersinia antibodies in yersinia triggered reactive arthritis.

Authors:  K Granfors; A Toivanen
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

10.  Relation between bone erosions and rheumatoid factor isotypes.

Authors:  J A Arnason; T Jónsson; A Brekkan; K Sigurjónsson; H Valdimarsson
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.